Camovis GmbH blog – All posts

Patient safety

Written by Carolin Kurth | Sep 1, 2026, 7:50:06 AM

– even beyond traditional study sites.

 

Patient safety first in decentralized and hybrid trials

In decentralized and hybrid trials, patient safety always comes first. Even outside classical study sites, protection, oversight, and compliance must be ensured without compromise.

 

The challenges behind decentralized trial conduct
 
Everyday challenges include:


Off-site patient visits require careful planning and close supervision, while digital tools, eDiaries, and medical devices must be used correctly and consistently. At the same time, seamless communication between patients, study sites, sponsors, and CROs is essential to keep all stakeholders aligned. Without clearly defined processes, patient safety may be at risk, data quality can suffer, and study operations may come to a standstill.



Safe, structured, and compliant DCT support

Our DCT services ensure safe trial conduct, everywhere. Whether home visits, virtual visits, remote support, or patient coordination, our research professionals work according to clearly defined roles, structured processes, and EU recommendations for decentralized trials. We support patients throughout the entire study lifecycle, coordinate communication between all stakeholders, and ensure complete, transparent documentation.

 

Combining flexibility with the highest standards

This is how we combine flexibility and patient-centricity with the highest standards of quality, compliance, and protection – patient safety without compromise, no matter where the study takes place.


Interested in learning more about our DCT Services?